Axel Wester

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2

Teresa Brevini, Mailis Maes, Gwilym J. Webb et al. · Nature · 2022 · 294 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis

Patrik Nasr, Axel Wester, Mattias Ekstedt et al. · Clinical Gastroenterology and Hepatology · 2024 · 70 citations · Full text

Medicine, Internal Medicine, Pathology +17

Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes

Axel Wester, Ying Shang, Emilie Toresson Grip et al. · Gut · 2024 · 61 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden

Ying Shang, Rickard Strandberg, Hannes Hagström et al. · Journal of Hepatology · 2025 · 46 citations · Full text

Medicine, Biostatistics, Internal Medicine +13

Peripheral artery disease and outcomes in patients with acute myocardial infarction

Rubina Attar, Axel Wester, Sasha Koul et al. · Open Heart · 2019 · 44 citations · Full text

Medicine, Cardiology, Internal Medicine +17